Original Article

Cost-effectiveness Strategies to Treat Osteoporosis in Elderly Women

Background: Comparing the cost-effectiveness of various antiosteoporotic drugs has not been defined. Methods: We determined the cost-effectiveness of calcitonin, raloxifene, bisphosphates and PTH in a base-case cohort of women aged 65 or older with osteoporosis. After bone densitometry, women were stratified into groups of treatment or no treatment. Our outcome…

Posted in: compliance 4 cost effectiveness 3 Osteoporosis 29